Bite 4: Triple negative breast cancer


Finish all modules to obtain your certification

Module 15 modules

5 modules

The heterogeneity of TNBC: are we ready to implement the biological knowledge in the clinical practice?

Dr. Phillipe Aftimos, Institut Jules Bordet (Brussels, Belgium)
Dr. Mafalda Oliveira, Hospital Vall d’Hebron/VHIO (Barcelona, Spain)

Module 24 módulos

4 módulos

Treatment of early TNBC: what is the current optimal algorithm?

Dr. Sara López Tarruella, Hospital General Universitario Gregorio Marañón (Madrid, Spain)
Dr. Mireia Margelí, Institut Català d’Oncologia-Badalona (Barcelona, Spain)

Module 34 módulos

4 módulos

Immunotherapy in early TNBC

Dr. Marta Santisteban, Clínica Universidad de Navarra (Pamplona, Spain)
Dr. Luis de la Cruz, Hospital Universitario Virgen Macarena (Sevilla, Spain)

Module 44 módulos

4 módulos

Using biomarkers to define the best first-line strategy in mTNBC

Dr. Roberto Salgado, GZA-ZNA Hospitals (Antwerp, Belgium), Peter Mac Callum Cancer Centre (Melbourne, Australia)
Dr. Vicente Peg, Hospital Universitario Valle de Hebrón (Barcelona, Spain)

Module 54 módulos

4 módulos

Novel treatment approaches in mTNBC

Dr. Kevin Punie, UZ Leuven (Leuven, Belgium)
Dr. Arlindo Ferreira, Champalimaud Foundation (Lisbon, Portugal)

If you have doubts about any of the aspects of the syllabus, you can send us an email to and we will respond as soon as possible.